UV TRANSILLUMINATOR AND CHEMILUMINESCENE INAGING SYSTEM TRA

Where this opportunity stands

Every notice posted under solicitation 75N98026Q00891AZUREBIOSYSTEMS in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Answer the notice: this is when the requirement can still be shaped.
• Contact the contracting officer named on the notice.
• Check who won similar work; they are the likely bidders.

Who won similar work

258 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (191): middle half $115K to $19.9M, median $1.4M; range $12K to $89.0B.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and AnalyzerNo listed company matched (Materiality N/A)
• Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
• Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESMateriality: 0.11% of $TMO revenue (Low) SEC
• Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
• Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
• Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
• Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
• Sep 30, 2026Washington Metropolitan Area Transit Authority Washington DC 20024 USA$23.8MNIH TRANShare Program -WMATA SmartBenefits� Program Transit Benefit ServicesNo listed company matched (Materiality N/A)
• Sep 29, 2026THE BROAD INSTITUTE, INC$215KWhole genome sequencing for investigation of age-related chronic disease in HANDLS participantsNo listed company matched (Materiality N/A)
• Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.